Narus Financial Partners, LLC Johnson & Johnson Transaction History

Narus Financial Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Oct 12, 2023	SELL	$160.2 - $179.79 $17,301 - $19,417	-108 Reduced 7.25%	1,381 $244 Million
Q3 2022 Oct 12, 2023	BUY	$161.33 - $179.52 $240,220 - $267,305	1,489 New	1,489 $243 Million
Q2 2022 Oct 12, 2023	BUY	$168.19 - $186.01 $249,089 - $275,480	1,481 New	1,481 $263 Million
Q1 2022 Sep 12, 2023	BUY	$158.14 - $179.59 $231,516 - $262,919	1,464 New	1,464 $259 Million
Q1 2021 Mar 07, 2024	BUY	$153.07 - $170.48 $235,115 - $261,857	1,536 New	1,536 $252 Million

4,275

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Narus Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Narus Financial Partners, LLC with notifications on news.